Application of Cas9‐Based Gene Editing to Engineering of Nonribosomal Peptide Synthetases
ChemBioChem · 2025
DOI: 10.1002/cbic.202400765 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift ChemBioChem, 2025. Verfasst von Takuya Hashimoto und 2 weiteren Autor:innen. Beteiligte Einrichtung: Bioproduction Research Institute, National Institute of Advanced Industrial Science and Technology, 1-1-1 Higashi, Tsukuba, Ibaraki, 305-8566, Japan. Hauptthemen laut MEDLINE: Peptide Synthases, Gene Editing, CRISPR-Cas Systems, Protein Engineering. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 64 Literaturangaben. Gefördert von: JSPS.
Abstract (Originalsprache)
Engineering of nonribosomal peptide synthetases (NRPSs) could transform the production of bioactive natural product derivatives. A number of recent reports have described the engineering of NRPSs without marked reductions in yield. Comparative analysis of evolutionarily related NRPSs can provide insights regarding permissive fusion sites for engineering where recombination may occur during evolutionary processes. Studies involving engineering of NRPSs using these recombination sites showed that they have great potential. Moreover, we highlight recent advances in engineering of NRPSs using CRISPR‐associated protein 9 (Cas9)‐based gene editing technology. The use of Cas9 facilitates the editing of even larger biosynthetic gene clusters (BGCs) close to or over 100 kb in size by precisely targeting and digesting DNA sequences at specific sites. This technology combined with growing understanding of potential fusion sites from large‐scale informatics analyses will accelerate the scalable exploration of engineered NRPS assembly lines to obtain bioactive natural product derivatives in high yields.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Bioproduction Research Institute, National Institute of Advanced Industrial Science and Technology, 1-1-1 Higashi, Tsukuba, Ibaraki, 305-8566, Japan.
- Department Cellular and Molecular Biotechnology Research Institute, National Institute of Advanced Industrial Science and Technology, 2-4-7 Aomi, Koto-ku, Tokyo, 135-0064, Japan.
ORCID-Profile: Takuya Hashimoto, Hikaru Suenaga, Kazuo Shin-Ya
Förderung
- JSPS
Zitieren
APA
Hashimoto, T., Suenaga, H., & Shin-Ya, K. (2025). Application of Cas9‐Based Gene Editing to Engineering of Nonribosomal Peptide Synthetases. ChemBioChem. https://doi.org/10.1002/cbic.202400765
Vancouver
Hashimoto T, Suenaga H, Shin-Ya K. Application of Cas9‐Based Gene Editing to Engineering of Nonribosomal Peptide Synthetases. ChemBioChem. 2025. doi:10.1002/cbic.202400765
BibTeX
@article{Hashimoto2025,
author = {Hashimoto, Takuya and Suenaga, Hikaru and Shin-Ya, Kazuo},
title = {Application of Cas9‐Based Gene Editing to Engineering of Nonribosomal Peptide Synthetases},
journal = {ChemBioChem},
year = {2025},
doi = {10.1002/cbic.202400765}
}
EUVIMED